<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Referred-in-Senate" dms-id="H08ACB3D6E9424CBFB74273B7AA826052" public-private="public" key="G" bill-type="olc" stage-count="1"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 4531 : Support for Patients and Communities Reauthorization Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date></dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">IIB</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4531</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date>December 13, 2023</action-date><action-desc>Received; read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>AN ACT</legis-type><official-title display="yes">To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.</official-title></form><legis-body id="H8C617D4ED2374E12B3B0DE504D8CCBC9" style="OLC"><section id="H325E80D22DEE476C9816EC67E02356BC" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Support for Patients and Communities Reauthorization Act</short-title></quote>.</text></section><section id="H19D3C66CAFED48289B2BFEE7FC5EDC2A"><enum>2.</enum><header>Table of contents</header><text display-inline="no-display-inline">The table of contents for this Act is as follows:</text><toc container-level="legis-body-container" quoted-block="no-quoted-block" lowest-level="section" regeneration="yes-regeneration" lowest-bolded-level="division-lowest-bolded"><toc-entry idref="H325E80D22DEE476C9816EC67E02356BC" level="section">Sec. 1. Short title.</toc-entry><toc-entry idref="H19D3C66CAFED48289B2BFEE7FC5EDC2A" level="section">Sec. 2. Table of contents.</toc-entry><toc-entry idref="HA1F7FA82B69E4A37849A30FB72C1C552" level="title">Title I—Public Health</toc-entry><toc-entry idref="HDA658A065F6A4704AF19578B48BFD020" level="section">Sec. 101. Prenatal and postnatal health.</toc-entry><toc-entry idref="HA8F3B579FFAB4E10829B143EAC5299B7" level="section">Sec. 102. Monitoring and education regarding infections associated with illicit drug use and other risk factors.</toc-entry><toc-entry idref="HAFF43939A7E44C889777410BCD017888" level="section">Sec. 103. Preventing overdoses of controlled substances.</toc-entry><toc-entry idref="H75C5896178A4445F89EEB7312614D4C8" level="section">Sec. 104. Residential treatment programs for pregnant and postpartum women.</toc-entry><toc-entry idref="H88AF73215AEB42FBB3FB8B5DFE847558" level="section">Sec. 105. Youth prevention and recovery.</toc-entry><toc-entry idref="H8850E16F6A404BFEBFC55B38001AE556" level="section">Sec. 106. First responder training.</toc-entry><toc-entry idref="H597FA844C9624BEC912B5F0B95F4A57C" level="section">Sec. 107. Building communities of recovery.</toc-entry><toc-entry idref="HDB551CB163FC4649B1D962B7E5A46594" level="section">Sec. 108. National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.</toc-entry><toc-entry idref="HF906D1299BB84724A0B1082879E07122" level="section">Sec. 109. Comprehensive opioid recovery centers.</toc-entry><toc-entry idref="HF0A123EBB1E3427991DB161D0D7819AA" level="section">Sec. 110. Grants to address the problems of persons who experience violence related stress.</toc-entry><toc-entry idref="H1759F36B9A7D4332A25CE305F2626F1C" level="section">Sec. 111. Mental and behavioral health education and training grants.</toc-entry><toc-entry idref="H0A42275161114E03B5551150F05B3D10" level="section">Sec. 112. Loan repayment program for the substance use disorder treatment workforce.</toc-entry><toc-entry idref="H6DA8F2B0A5C84947A272CDD56807F07E" level="section">Sec. 113. Pilot program for public health laboratories to detect fentanyl and other synthetic opioids.</toc-entry><toc-entry idref="HBB14526F176F41F29DE51340BCC4B457" level="section">Sec. 114. Monitoring and reporting of child, youth, and adult trauma.</toc-entry><toc-entry idref="HD36689486B7C40EB9C384FF439D32754" level="section">Sec. 115. Task force to develop best practices for trauma-informed identification, referral, and support.</toc-entry><toc-entry idref="H6A1579F8B7F642088E18513B1ABED9CB" level="section">Sec. 116. Treatment, recovery, and workforce support grants.</toc-entry><toc-entry idref="H014F4C879D5549AEA8AD5A9869F38693" level="section">Sec. 117. Grant program for State and Tribal response to opioid use disorders.</toc-entry><toc-entry idref="H95F3145B61314A0BA648BB6C4E13CA79" level="section">Sec. 118. References to opioid overdose reversal agents in HHS grant programs.</toc-entry><toc-entry idref="H74BBF0C790B1472C99E713DBF71B5F9C" level="section">Sec. 119. Addressing other concurrent substance use disorders through grant program for State and Tribal response to opioid use disorders.</toc-entry><toc-entry idref="HFD85353894F445828BB290D86E2C580C" level="section">Sec. 120. Providing for a study on the effects of remote monitoring on individuals who are prescribed opioids.</toc-entry><toc-entry idref="HE940344D744F40BF8E1DE86155F1B332" level="title">Title II—Controlled Substances</toc-entry><toc-entry idref="HF80233AADAC946A9A3B3B72DBC23BE36" level="section">Sec. 201. Delivery of certain substances by a pharmacy to an administering practitioner.</toc-entry><toc-entry idref="H9B8D860D59D240C8BC8F968D6DC52B85" level="section">Sec. 202. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone.</toc-entry><toc-entry idref="H0799F273966147DCA4C0532ADAEB3088" level="section">Sec. 203. Combating illicit xylazine.</toc-entry><toc-entry idref="H1AD0519841FA433E911FAE0C980D6CE3" level="section">Sec. 204. Technical corrections.</toc-entry><toc-entry idref="H7AAAD4909D224CFB9CF3CA70635ED4DE" level="section">Sec. 205. Required training for prescribers of controlled substances.</toc-entry><toc-entry idref="H4DF0EB27199647F9BD4D71E1D672C354" level="title">Title III—Medicaid</toc-entry><toc-entry idref="H005E8ED40E684D088FF92B2BAD78D66E" level="section">Sec. 301. Extending requirement for State Medicaid plans to provide coverage for medication-assisted treatment.</toc-entry><toc-entry idref="H9495CBC6C35F46D0AE1E4AD5CF0181F5" level="section">Sec. 302. Expanding required reports on T-MSIS substance use disorder data to include mental health condition data.</toc-entry><toc-entry idref="H242B652BD477443EB30006B12B73A02A" level="section">Sec. 303. Monitoring prescribing of antipsychotic medications.</toc-entry><toc-entry idref="H30662AECD0C344BD98FA820E62B367B9" level="section">Sec. 304. Lifting the IMD exclusion for substance use disorder.</toc-entry><toc-entry idref="HE83C43754E094EDD8B4A46545538CBD4" level="section">Sec. 305. Prohibition on termination of enrollment due to incarceration.</toc-entry><toc-entry idref="HD129DAEE886F4FE0AD8468A1CE7D33E5" level="section">Sec. 306. State option relating to inmates who are pregnant women pending disposition of charges.</toc-entry><toc-entry idref="HDC107FEBDE4C4E2AA656E6E2BA052FF4" level="section">Sec. 307. Permitting access to medical assistance under the Medicaid program for foster youth.</toc-entry><toc-entry idref="HFE0DDC1805094EDFB7A821787DCFF7B6" level="title">Title IV—Offsets</toc-entry><toc-entry idref="H09269317D65F459A94CE372040E77C46" level="section">Sec. 401. Promoting value in Medicaid managed care.</toc-entry></toc></section><title id="HA1F7FA82B69E4A37849A30FB72C1C552"><enum>I</enum><header>Public Health</header><section id="HDA658A065F6A4704AF19578B48BFD020"><enum>101.</enum><header>Prenatal and postnatal health</header><text display-inline="no-display-inline">Section 317L(d) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-13">42 U.S.C. 247b–13(d)</external-xref>) is amended by striking <quote>such sums as may be necessary for each of the fiscal years 2019 through 2023</quote> and inserting <quote>$4,250,000 for each of fiscal years 2024 through 2028</quote>. </text></section><section id="HA8F3B579FFAB4E10829B143EAC5299B7"><enum>102.</enum><header>Monitoring and education regarding infections associated with illicit drug use and other risk factors</header><text display-inline="no-display-inline">Section 317N of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b-15">42 U.S.C. 247b–15</external-xref>) is amended—</text><paragraph id="H2878D91B863B44BF8EDA8FB44525BF14"><enum>(1)</enum><text>in the section heading, by striking <quote><header-in-text level="section" style="OLC">Surveillance and</header-in-text></quote> and inserting <quote><header-in-text level="section" style="OLC">Monitoring and</header-in-text></quote> ; and</text></paragraph><paragraph id="H0EEBB5315C194576A61E09C623297C30"><enum>(2)</enum><text>in subsection (d), by striking <quote>fiscal years 2019 through 2023</quote> and inserting <quote>fiscal years 2024 through 2028</quote>.</text></paragraph></section><section id="HAFF43939A7E44C889777410BCD017888"><enum>103.</enum><header>Preventing overdoses of controlled substances</header><subsection id="H4E4E092989BC4CBD8431FC02B8E6D31A"><enum>(a)</enum><header>Evidence-based prevention grants</header><text display-inline="yes-display-inline">Section 392A(a)(2)(D) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280b-1">42 U.S.C. 280b–1(a)(2)(D)</external-xref>) is amended by inserting after <quote>new and emerging public health crises</quote> the following: <quote>, such as the fentanyl crisis,</quote>.</text></subsection><subsection id="H0B8654A2C82F41EE990F86FA22D8ABD7" display-inline="no-display-inline"><enum>(b)</enum><header>Use of grants by States, localities, and Indian Tribes to conduct wastewater surveillance</header><text>Section 392A(a)(3)(A) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280b-1">42 U.S.C. 280b–1(a)(3)(A)</external-xref>) is amended by inserting <quote>, including through the use of wastewater surveillance to identify trends associated with controlled substance use if it is determined by appropriate evidence that wastewater surveillance is an effective way to survey controlled substance use within a community</quote> before the semicolon.</text></subsection><subsection id="H8AA651D038E04D318A02EE454BB7CD30"><enum>(c)</enum><header>Authorization of appropriations</header><text>Section 392A(e) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280b-1">42 U.S.C. 280b–1(e)</external-xref>) is amended by striking <quote>$496,000,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$505,579,000 for each of fiscal years 2024 through 2028</quote>.</text></subsection></section><section id="H75C5896178A4445F89EEB7312614D4C8"><enum>104.</enum><header>Residential treatment programs for pregnant and postpartum women</header><text display-inline="no-display-inline">Section 508(s) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-1">42 U.S.C. 290bb–1(s)</external-xref>) is amended by striking <quote>$29,931,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$38,931,000 for each of fiscal years 2024 through 2028</quote>.</text></section><section id="H88AF73215AEB42FBB3FB8B5DFE847558"><enum>105.</enum><header>Youth prevention and recovery</header><text display-inline="no-display-inline">Section 7102(c)(9) of the SUPPORT for Patients and Communities Act (42 U.S.C. 290bb–7a(c)(9)) is amended by striking <quote>fiscal years 2019 through 2023</quote> and inserting <quote>fiscal years 2024 through 2028</quote>.</text></section><section id="H8850E16F6A404BFEBFC55B38001AE556"><enum>106.</enum><header>First responder training</header><text display-inline="no-display-inline">Section 546(h) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-1">42 U.S.C. 290ee–1(h)</external-xref>) is amending by striking <quote>$36,000,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$56,000,000 for each of fiscal years 2024 through 2028</quote>.</text></section><section id="H597FA844C9624BEC912B5F0B95F4A57C"><enum>107.</enum><header>Building communities of recovery</header><text display-inline="no-display-inline">Section 547(f) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-2">42 U.S.C. 290ee–2(f)</external-xref>) is amended by striking <quote>$5,000,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$16,000,000 for each of fiscal years 2024 through 2028</quote>. </text></section><section id="HDB551CB163FC4649B1D962B7E5A46594"><enum>108.</enum><header>National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support</header><text display-inline="no-display-inline">Section 547A(e) of the Public Health Service Act (42 U.S.C. 290ee–2a(e)) is amended by striking <quote>$1,000,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$2,000,000 for each of fiscal years 2024 through 2028</quote>.</text></section><section id="HF906D1299BB84724A0B1082879E07122"><enum>109.</enum><header>Comprehensive opioid recovery centers</header><subsection id="HA5C970DF619F4C94A318633644BEBAED"><enum>(a)</enum><header>Reauthorization</header><text>Section 552(j) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-7">42 U.S.C. 290ee–7(j)</external-xref>) is amended by striking <quote>2019 through 2023</quote> and inserting <quote>2024 through 2028</quote>.</text></subsection><subsection id="H67325F2AC156416FBC5D3347F29BE60C"><enum>(b)</enum><header>Documentation for evidence of capacity To carry out required activities</header><text>Section 552(d) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-7">42 U.S.C. 290ee–7(d)</external-xref>) is amended by adding at the end the following: </text><quoted-block style="OLC" id="HDBBB2DAF9B7443C28D5E642492112674" display-inline="no-display-inline"><paragraph id="HB25894D4436449B48FB7D56356500A24"><enum>(3)</enum><header>Documentation</header><subparagraph id="HF105423FAC58403DA48EC1C796BB777D"><enum>(A)</enum><header>In general</header><text>Evidence required to be provided under paragraph (1) may be provided through a letter of intent from partner agencies or other relevant documentation (as defined by the Secretary).</text></subparagraph><subparagraph id="H409BDCD1E1444C7FA435D1BAB8E40F85"><enum>(B)</enum><header>Partner agency defined</header><text display-inline="yes-display-inline">In this paragraph, the term <term>partner agency</term> means a non-governmental organization or other public or private entity—</text><clause id="H0D61E32F14204798AEC107BBC9FC65A1"><enum>(i)</enum><text>the primary purpose of which is the delivery of mental health or substance use disorder treatment services; and</text></clause><clause id="HAE52455168234661911E325BF40BC191"><enum>(ii)</enum><text display-inline="yes-display-inline">with which the applicant coordinates to provide the full continuum of treatment services (as specified in subsection (g)(1)(B)) that the applicant is unable to offer on site.</text></clause></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HB2D92480A9E643FA81710574E24BC27C"><enum>(c)</enum><header>Center activities carried out through third parties</header><text display-inline="yes-display-inline">Section 552(g) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-7">42 U.S.C. 290ee–7(g)</external-xref>) is amended in the matter preceding paragraph (1) by striking <quote>Each Center shall</quote> and all that follows through <quote>subsection (f):</quote> and inserting the following: <quote>Each Center shall, at a minimum, carry out the activities specified in this subsection directly, through referral, or through contractual arrangements. If a Center elects to carry out such activities through contractual arrangements, the Secretary may issue guidance on best practices to ensure that the Center is capable of carrying out such activities, including carrying out such activities through technology-enabled collaborative learning and capacity building models described in subsection (f) and coordinating the full continuum of treatment services specified in subparagraph (B). Such activities include the following:</quote>. </text></subsection></section><section id="HF0A123EBB1E3427991DB161D0D7819AA"><enum>110.</enum><header>Grants to address the problems of persons who experience violence related stress</header><text display-inline="no-display-inline">Section 582(j) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290hh-1">42 U.S.C. 290hh–1(j)</external-xref>) is amended by striking <quote>$63,887,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$93,887,000 for each of fiscal years 2024 through 2028</quote>.</text></section><section id="H1759F36B9A7D4332A25CE305F2626F1C"><enum>111.</enum><header>Mental and behavioral health education and training grants</header><text display-inline="no-display-inline">Section 756(f) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/294e-1">42 U.S.C. 294e–1(f)</external-xref>) is amended by striking <quote>fiscal years 2023 through 2027</quote> and inserting <quote>fiscal years 2024 through 2028</quote>.</text></section><section id="H0A42275161114E03B5551150F05B3D10"><enum>112.</enum><header>Loan repayment program for the substance use disorder treatment workforce</header><text display-inline="no-display-inline">Section 781(j) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/295h">42 U.S.C. 295h(j)</external-xref>) is amended by striking <quote>$25,000,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$40,000,000 for each of fiscal years 2024 through 2028</quote>.</text></section><section id="H6DA8F2B0A5C84947A272CDD56807F07E"><enum>113.</enum><header>Pilot program for public health laboratories to detect fentanyl and other synthetic opioids</header><subsection id="HDD49F4C48A0D48C29C5A46446CDBEDA4"><enum>(a)</enum><header>Detection activities</header><text>Section 7011(b) of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-10">42 U.S.C. 247d–10</external-xref> note) is amended—</text><paragraph id="H73CAA1A8AEAE4AA691AB8A2510B83D42"><enum>(1)</enum><text>in paragraph (2), by striking <quote>and</quote> at the end;</text></paragraph><paragraph id="H7B0ABCB51CCC40299D659A9E15FB943D"><enum>(2)</enum><text>in paragraph (3), by striking the period at the end and inserting <quote>; and</quote>; and</text></paragraph><paragraph id="HD6A99270610A43A0B4937F7DC4C8223D"><enum>(3)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HFA120295F4324F83944109E49B4B8060"><paragraph id="H382F1D66251C49FD928B3A4CC1A0FD4A"><enum>(4)</enum><text display-inline="yes-display-inline">public, private, and academic entities with expertise in detection and testing activities, such as wastewater surveillance, with respect to synthetic opioids, including fentanyl and its analogues.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="H9B04DCAEE19A49CBA1E1AC28EF1D0C3A"><enum>(b)</enum><header>Authorization of appropriations</header><text display-inline="yes-display-inline">Section 7011(d) of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-10">42 U.S.C. 247d–10(d)</external-xref>) is amended by striking <quote>fiscal years 2019 through 2023</quote> and inserting <quote>fiscal years 2024 through 2028</quote>.</text></subsection></section><section id="HBB14526F176F41F29DE51340BCC4B457"><enum>114.</enum><header>Monitoring and reporting of child, youth, and adult trauma</header><text display-inline="no-display-inline">Section 7131(e) of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/42/242t">42 U.S.C. 242t(e)</external-xref>) is amended by striking <quote>$2,000,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$9,000,000 for each of fiscal years 2024 through 2028</quote>.</text></section><section id="HD36689486B7C40EB9C384FF439D32754"><enum>115.</enum><header>Task force to develop best practices for trauma-informed identification, referral, and support</header><text display-inline="no-display-inline">Section 7132 of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="public-law" parsable-cite="pl/115/271">Public Law 115–271</external-xref>) is amended—</text><paragraph id="H1DCACA198E224985B9C5C0522AE06C66"><enum>(1)</enum><text>in subsection (g)—</text><subparagraph id="H2A11A5B9CB2D4CFE81CB4AFD059236B4"><enum>(A)</enum><text display-inline="yes-display-inline">in paragraph (1), by striking <quote>and</quote> at the end;</text></subparagraph><subparagraph id="H3C52234D2E2A4CBDBDC58878008BB499"><enum>(B)</enum><text>in paragraph (2), by striking the period at the end and inserting <quote>; and</quote>; and</text></subparagraph><subparagraph id="HE68F3D076F694EC89122A080F88B221F"><enum>(C)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" id="H3626959B03FE4AF09A9701D2A967B0A7" display-inline="no-display-inline"><paragraph id="H47F0E34200404F3589AE68CCB96510FF"><enum>(3)</enum><text display-inline="yes-display-inline">additional reports and updates to existing reports, as necessary.</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H4137188A45DC4FFEB688F4E74E979E03"><enum>(2)</enum><text>by amending subsection (i) to read as follows:</text><quoted-block style="OLC" id="H168CC5E7093E41AA8E865A83C4582DF0" display-inline="no-display-inline"><subsection id="H7C1B0B82E7914146ADA426E880053F68"><enum>(i)</enum><header>Sunset</header><text display-inline="yes-display-inline">The task force shall sunset on September 30, 2026.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section><section commented="no" display-inline="no-display-inline" section-type="subsequent-section" id="H6A1579F8B7F642088E18513B1ABED9CB"><enum>116.</enum><header display-inline="yes-display-inline">Treatment, recovery, and workforce support grants</header><text display-inline="no-display-inline">Section 7183 of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-8">42 U.S.C. 290ee–8</external-xref>) is amended—</text><paragraph commented="no" display-inline="no-display-inline" id="H211E8977514A41CC8872B684A875B101"><enum>(1)</enum><text display-inline="yes-display-inline">in subsection (b), by inserting <quote>each</quote> before <quote>for a period</quote>;</text></paragraph><paragraph id="HBF6E79EA2D4A46658BD1C20CF2741137"><enum>(2)</enum><text>by amending subsection (c)(2) to read as follows:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HC2F4EE97603A4E119628BFDEC79CE0F2"><paragraph commented="no" display-inline="no-display-inline" id="H3EC40CB70CCF402CBAA06E145567FB57"><enum>(2)</enum><header display-inline="yes-display-inline">Rates</header><text display-inline="yes-display-inline">The rates described in this paragraph are the following:</text><subparagraph commented="no" display-inline="no-display-inline" id="H1DE7C99BFCC44C8E887762AB1CD245D0"><enum>(A)</enum><text>The amount by which the average rate of drug overdose deaths in the State, adjusted for age, for the period of 5 calendar years for which there is available data, including if necessary provisional data, immediately preceding the grant cycle (which shall be the period of calendar years 2018 through 2022 for the first grant cycle following the enactment of the <short-title>Support for Patients and Communities Reauthorization Act</short-title>) is above the average national overdose mortality rate, as determined by the Director of the Centers for Disease Control and Prevention, for the same period.</text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="H035C96D2645944F08EE7F0A2C5CF18ED"><enum>(B)</enum><text>The amount by which the average rate of unemployment for the State, based on data provided by the Bureau of Labor Statistics, for the period of 5 calendar years for which there is available data, including if necessary provisional data, immediately preceding the grant cycle (which shall be the period of calendar years 2018 through 2022 for the first grant cycle following the enactment of the <short-title>Support for Patients and Communities Reauthorization Act</short-title>) is above the national average for the same period.</text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="H7BF92732B555401E9F2F6533CBB9F83C"><enum>(C)</enum><text>The amount by which the average rate of labor force participation in the State, based on data provided by the Bureau of Labor Statistics, for the period of 5 calendar years for which there is available data, including if necessary provisional data, immediately preceding the grant cycle (which shall be the period of calendar years 2018 through 2022 for the first grant cycle following the enactment of the <short-title>Support for Patients and Communities Reauthorization Act</short-title>) is below the national average for the same period.</text></subparagraph></paragraph><after-quoted-block>;</after-quoted-block></quoted-block></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H10ADFD1E6E5C4B979774DF48EEF203B0"><enum>(3)</enum><text>in subsection (g)—</text><subparagraph commented="no" display-inline="no-display-inline" id="HFB6F3C49E056491D84AE2A508CC3E6A3"><enum>(A)</enum><text display-inline="yes-display-inline">in paragraphs (1) and (3), by redesignating subparagraphs (A) and (B) as clauses (i) and (ii), respectively, and adjusting the margins accordingly;</text></subparagraph><subparagraph id="H5E905E4FD9174110A4EBE08E8465D723"><enum>(B)</enum><text>by redesignating paragraphs (1) through (3) as subparagraphs (A) through (C), respectively, and adjusting the margins accordingly;</text></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="H4BC6A6C1D1224F11B9D95025ED9C6352"><enum>(C)</enum><text>by striking <quote>An entity</quote> and inserting the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H4FCC02227F404C809F13F0A80075E73B"><paragraph commented="no" display-inline="no-display-inline" id="H4A7FE13B08C74E31BF6F5A68E14F9CC0"><enum>(1)</enum><header>In general</header><text>An entity</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="HD8344EDC12B246BF8FFFCDF53AE426D4"><enum>(D)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HE1CE50AFFC2C497BB8C7EF5045B737E5"><paragraph commented="no" display-inline="no-display-inline" id="HAF352F2271F549FE9A35DD12F2566CCF"><enum>(2)</enum><header>Transportation services</header><text>An entity receiving a grant under this section may use not more than 5 percent of the funds for providing transportation for individuals to participate in an activity supported by a grant under this section, which transportation shall be to or from a place of work or a place where the individual is receiving vocational education or job training services or receiving services directly linked to treatment of or recovery from a substance use disorder.</text></paragraph><paragraph id="HF282C072FE984DBBA3A7E75F2A2C9B12"><enum>(3)</enum><header>No other authorized uses</header><text display-inline="yes-display-inline">An entity receiving a grant under this section may not use the funds for any activity other than the activities listed in paragraphs (1) and (2).</text></paragraph><after-quoted-block>;</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H503F1459BE5346AB8767536058D2536A"><enum>(4)</enum><text display-inline="yes-display-inline">in subsection (i)(2), by inserting <quote>, which shall include the employment and earnings outcomes as described in subclauses (I) and (III) of section 116(b)(2)(A)(i) of the Workforce Innovation and Opportunity Act (<external-xref legal-doc="usc" parsable-cite="usc/29/3141">29 U.S.C. 3141(b)(2)(A)(i)</external-xref>)</quote> after <quote>subsection (g)</quote>;</text></paragraph><paragraph commented="no" display-inline="no-display-inline" id="H9E5A9F1858FB44C39BF2E57E4938FB98"><enum>(5)</enum><text>in subsection (j)—</text><subparagraph commented="no" display-inline="no-display-inline" id="H4CCB3CAE72D748DEBB84EC924ED7836B"><enum>(A)</enum><text display-inline="yes-display-inline">in paragraph (1), by inserting <quote>for each grant cycle</quote> after <quote>grant period</quote>; and</text></subparagraph><subparagraph id="HE13A8B6C5F1F40178C0F77F261D9A09B" commented="no"><enum>(B)</enum><text>in paragraph (2)—</text><clause commented="no" display-inline="no-display-inline" id="HE136D6EA216042778C111C3AC25C9D8F"><enum>(i)</enum><text display-inline="yes-display-inline">in the matter preceding subparagraph (A)—</text><subclause commented="no" display-inline="no-display-inline" id="H60A0CB80374F49FA93A677EA6C8CC9E4"><enum>(I)</enum><text display-inline="yes-display-inline">by striking <quote>the preliminary report</quote> and inserting <quote>each preliminary report</quote>; and</text></subclause><subclause commented="no" display-inline="no-display-inline" id="HE07D6E3F9644418A89C8890302A314AF"><enum>(II)</enum><text>by inserting <quote>for the grant cycle</quote> after <quote>final report</quote>; and</text></subclause></clause><clause commented="no" display-inline="no-display-inline" id="H96B12BABAB624B8AA7C9A2D921C410E8"><enum>(ii)</enum><text>in subparagraph (A), by striking <quote>(g)(3)</quote> and inserting <quote>(g)(1)(C)</quote>; and</text></clause></subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="HBE93D3DC749340BA9ABEE23B58E1133A"><enum>(6)</enum><text>in subsection (k), by striking <quote>$5,000,000 for each of fiscal years 2019 through 2023</quote> and inserting <quote>$12,000,000 for each of fiscal years 2024 through 2028</quote>.</text></paragraph></section><section id="H014F4C879D5549AEA8AD5A9869F38693"><enum>117.</enum><header>Grant program for State and Tribal response to opioid use disorders</header><text display-inline="no-display-inline">Section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) is amended after <quote>which may include drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act</quote> by inserting <quote>or fentanyl or xylazine test strips</quote>.</text></section><section id="H95F3145B61314A0BA648BB6C4E13CA79"><enum>118.</enum><header>References to opioid overdose reversal agents in HHS grant programs</header><subsection id="HF6757FB6B7DC4A51AC080B55704D1E12"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall ensure that, as appropriate, whenever the Department of Health and Human Services issues a regulation or guidance for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal drug (such as a reference to naloxone) is inclusive of any opioid overdose reversal drug that has been approved under section 505 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355</external-xref>) for emergency treatment of a known or suspected opioid overdose.</text></subsection><subsection id="H4E2C09387D644A50BADADE4F00237F5B" commented="no"><enum>(b)</enum><header>Existing references</header><paragraph id="H516D780733644B3C9992789B4C773F7A" commented="no"><enum>(1)</enum><header>Update</header><text>Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services shall update all references described in paragraph (2) to be inclusive of any opioid overdose reversal drug that has been approved or otherwise authorized for use by the Food and Drug Administration.</text></paragraph><paragraph id="HCEF0C408D56147D9AF702EDFCEA6C4F3" commented="no"><enum>(2)</enum><header>References</header><text>A reference described in this paragraph is any reference to an opioid overdose reversal drug (such as naloxone) in any regulation or guidance of the Department of Health and Human Services that—</text><subparagraph id="HD63A55C85D5F4F4FAF5F75FC25038CE8" commented="no"><enum>(A)</enum><text>was issued before the date of enactment of this Act; and</text></subparagraph><subparagraph id="H386324D9540D4FFC8969DBDB59EBC058" commented="no"><enum>(B)</enum><text>is included in—</text><clause id="H90568CB5309E45C2BF06A7B14461A61C" commented="no"><enum>(i)</enum><text display-inline="yes-display-inline">the grant program for State and Tribal response to opioid use disorders under section 1003 of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note) (commonly referred to as <quote>State Opioid Response Grants</quote> and <quote>Tribal Opioid Response Grants</quote>); or</text></clause><clause id="HCD4B819AB3FB400583ADDD22515035D1" commented="no"><enum>(ii)</enum><text>the grant program for priority substance use disorder prevention needs of regional and national significance under section 516 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290bb-22">42 U.S.C. 290bb–22</external-xref>).</text></clause></subparagraph></paragraph></subsection></section><section id="H74BBF0C790B1472C99E713DBF71B5F9C" section-type="subsequent-section"><enum>119.</enum><header>Addressing other concurrent substance use disorders through grant program for State and Tribal response to opioid use disorders</header><subsection id="H218BF5FD072E4AEC814625E3AFBF3CF1"><enum>(a)</enum><header>Additional use of funds</header><text display-inline="yes-display-inline">Section 1003(b) of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note) is amended by adding at the end the following:</text><quoted-block style="OLC" id="HA71B7847D67F4343836A75AA9A9C9A82" display-inline="no-display-inline"><paragraph id="H5444B7B8D0A04070B0270B56CE2F8B44"><enum>(5)</enum><header>Other concurrent substance use disorders</header><text display-inline="yes-display-inline">The Secretary may authorize the recipient of a grant under this subsection, in addition to using the grant for activities described in paragraph (4) with respect to opioid misuse and use disorders and stimulant misuse and use disorders, to use the grant for similar activities with respect to other concurrent substance use disorders.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H6BBB11BD0EB64438B0EE690A09AE652C"><enum>(b)</enum><header>Annual report to Congress</header><text display-inline="yes-display-inline">Section 1003(f) of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note) is amended—</text><paragraph id="H1692C2FF37334656BD66D9AAC5F3CFF3"><enum>(1)</enum><text>in paragraph (2), strike <quote>and</quote> at the end;</text></paragraph><paragraph id="H7345CB19C39E45E0BB7D9F76237132E7"><enum>(2)</enum><text>in paragraph (3), strike the period at the end and insert a semicolon; and</text></paragraph><paragraph id="HB856E3AA4B5245D7B86CBA89BE8CB17F"><enum>(3)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" id="H82A6CE40152140039969D043DF788C8B" display-inline="no-display-inline"><paragraph id="HB6A0A526A0D840C5B71338CDA6134A50"><enum>(4)</enum><text display-inline="yes-display-inline">the amount of funds each State that received a grant under subsection (b) received for the 12-month grant cycle covered by the report;</text></paragraph><paragraph id="H9BD363CC014C48DC8714FB83114DA398"><enum>(5)</enum><text display-inline="yes-display-inline">the amount of grant funds each such State spent for such grant cycle, disaggregated by the uses for which such funds were spent, including each allowable use under paragraphs (4) and (5) of subsection (b);</text></paragraph><paragraph id="HC455458A30324E1EBECC06B8E327DB53"><enum>(6)</enum><text display-inline="yes-display-inline">how many such States for such grant cycle did not spend all of the grant funds before such grant cycle expired;</text></paragraph><paragraph id="HABDC706FFA2F48ED91535E6E5C51A78C"><enum>(7)</enum><text display-inline="yes-display-inline">how many such States for such grant cycle requested no-cost extensions to extend the grant cycle; and</text></paragraph><paragraph id="H1DA655C38A8C400E9763583FA7A71CB1"><enum>(8)</enum><text display-inline="yes-display-inline">challenges for such States to spend all of the funds allocated and the reason for such challenges, including to what extent reporting requirements or other requirements placed an increased burden on the ability of such States to spend all of the funds.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="H3861CE7BEF6849DDBE6D74A186FFA29B"><enum>(c)</enum><header>Other concurrent substance use disorders defined</header><text display-inline="yes-display-inline">Section 1003(h) of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note) is amended—</text><paragraph id="HB524D477DC084F78B3DABF9539FEB65E"><enum>(1)</enum><text>by redesignating paragraphs (2) through (4) as paragraphs (3) through (5); and</text></paragraph><paragraph id="H361275D11CAA4F019811B772362EFFED"><enum>(2)</enum><text>by inserting before paragraph (3), as redesignated, the following:</text><quoted-block style="OLC" id="H0E1577B9F83C4DAFBADB1A1A5A21F00D" display-inline="no-display-inline"><paragraph id="HB4F5890E43104265B33A2130775B3617"><enum>(2)</enum><header>Other concurrent substance use disorders</header><text display-inline="yes-display-inline">The term <term>other concurrent substance use disorders</term> means—</text><subparagraph id="H45C40A3D7749420EAE6F7DD91675FF00"><enum>(A)</enum><text>alcohol use disorders co-occurring with opioid misuse and use disorders as a primary disorder; or</text></subparagraph><subparagraph id="H506A07094CDC44C8946AFAC46238ED7D"><enum>(B)</enum><text>alcohol use disorders co-occurring with stimulant misuse and use disorders as a primary disorder.</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="H54A4E75D99A14AA0B3DC6BB8ABDADA9D"><enum>(d)</enum><header>Rule of construction</header><text display-inline="yes-display-inline">Nothing in this Act or the amendments made by this Act shall be construed to change the allocation of funds among grantees pursuant to the minimum allocations and formula methodology under section 1003 of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/42/290ee-3">42 U.S.C. 290ee–3</external-xref> note). </text></subsection></section><section id="HFD85353894F445828BB290D86E2C580C"><enum>120.</enum><header>Providing for a study on the effects of remote monitoring on individuals who are prescribed opioids</header><subsection id="H609AEB01D3F642B685B9E4F700D7A892"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall conduct a study and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions and the Committee on Finance of the Senate a report on the use of remote monitoring with respect to individuals who are prescribed opioids.</text></subsection><subsection id="HC1A700C550F44F8FAAA7B809D227215B"><enum>(b)</enum><header>Report</header><text display-inline="yes-display-inline">The report described in subsection (a) shall include to the extent information is available and reliable—</text><paragraph id="HA3519A2BA325456D8AC5DD970AE2506D"><enum>(1)</enum><text>an assessment of scientific evidence related to the efficacy, individual outcomes, and potential cost savings associated with remote monitoring for individuals who are prescribed opioids compared to such individuals who are not so monitored;</text></paragraph><paragraph id="H76D6F23E9A47456F9DB62C89A6EC659D"><enum>(2)</enum><text>an assessment of the current prevalence of remote monitoring for individuals who are prescribed opioids, including the use of such monitoring for such individuals in other countries; and</text></paragraph><paragraph id="H767A210B12664498A8141101A3CF03AF"><enum>(3)</enum><text display-inline="yes-display-inline">information, including recommendations as appropriate, to improve availability, access, and coverage for remote monitoring for individuals who are prescribed opioids, including through changes to Federal health care programs (as defined in section 1128B of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1320a-7b">42 U.S.C. 1320a–7b</external-xref>)).</text></paragraph></subsection></section></title><title id="HE940344D744F40BF8E1DE86155F1B332"><enum>II</enum><header>Controlled Substances</header><section id="HF80233AADAC946A9A3B3B72DBC23BE36" section-type="subsequent-section"><enum>201.</enum><header>Delivery of certain substances by a pharmacy to an administering practitioner</header><text display-inline="no-display-inline">Paragraph (2) of section 309A(a) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/829a">21 U.S.C. 829a(a)</external-xref>) is amended to read as follows:</text><quoted-block style="OLC" id="HB865C8807A0D41F1B9048A471E05A944" display-inline="no-display-inline"><paragraph id="H8387094D546242F8BF269B928C74849C"><enum>(2)</enum><text display-inline="yes-display-inline">the controlled substance is a drug in schedule III, IV, or V that is, pursuant to the approval or licensure of such drug under the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act, to be administered by, or under the supervision of, the prescribing practitioner;</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></section><section id="H9B8D860D59D240C8BC8F968D6DC52B85"><enum>202.</enum><header>Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone</header><subsection id="H8E3F7C295AA241CDBCCB34575F4DE94C"><enum>(a)</enum><header>Secretary of HHS</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall, consistent with the requirements and procedures set forth in sections 201 and 202 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/811">21 U.S.C. 811</external-xref>; 812)—</text><paragraph id="HB476F7BDC27E494AB17407E63B60F892"><enum>(1)</enum><text display-inline="yes-display-inline">review the relevant data pertaining to the scheduling of products containing a combination of buprenorphine and naloxone that have been approved under section 505 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/355">21 U.S.C. 355</external-xref>); and</text></paragraph><paragraph id="HF94270A95C3A44C6BF5261243E1DC583"><enum>(2)</enum><text display-inline="yes-display-inline">if appropriate, request that the Attorney General initiate rulemaking proceedings to revise the schedules accordingly with respect to such products.</text></paragraph></subsection><subsection id="H4B0B77B0494144FE8B4A0462B48F35C9"><enum>(b)</enum><header>Attorney General</header><text display-inline="yes-display-inline">The Attorney General shall review any request made by the Secretary of Health and Human Services under subsection (a)(2) and determine whether to initiate proceedings to revise the schedules in accordance with the criteria set forth in sections 201 and 202 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/811">21 U.S.C. 811</external-xref>; 812).</text></subsection></section><section id="H0799F273966147DCA4C0532ADAEB3088"><enum>203.</enum><header>Combating illicit xylazine</header><subsection id="HCC8151DA98F14E2FB5B0CC4A5D5AD302"><enum>(a)</enum><header>Definitions</header><paragraph id="H97600E2A8F2C406AB67CDB9CF965D715" commented="no" display-inline="no-display-inline"><enum>(1)</enum><header display-inline="yes-display-inline">In general</header><text>In this section, the term <term>xylazine</term> has the meaning given the term in paragraph (60) of section 102 of the Controlled Substances Act, as added by paragraph (2).</text></paragraph><paragraph id="HB0E5D90FEB934A258B25ACD714824F87" commented="no" display-inline="no-display-inline"><enum>(2)</enum><header>Controlled Substances Act</header><text display-inline="yes-display-inline">Section 102 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802</external-xref>) is amended—</text><subparagraph id="HD87AC3AF958C4889BF75DC3B3E82683C" commented="no" display-inline="no-display-inline"><enum>(A)</enum><text display-inline="yes-display-inline">by redesignating the second paragraph (57) (relating to serious drug felony) and paragraph (58) as paragraphs (58) and (59), respectively;</text></subparagraph><subparagraph id="HB30841C0C7C8427B835A48A87526D326"><enum>(B)</enum><text>by moving the margin of paragraph (57) 2 ems to the left;</text></subparagraph><subparagraph id="H1605606BACEB4059848B6057395807C3"><enum>(C)</enum><text>by moving the margins of paragraphs (58) and (59), as redesignated, 2 ems to the left; and</text></subparagraph><subparagraph id="H44706E921D7548B8A5F0C7B19F788271" commented="no" display-inline="no-display-inline"><enum>(D)</enum><text display-inline="yes-display-inline">by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H63E1D8D185CA40C0861E1BCB01B8E188"><paragraph commented="no" display-inline="no-display-inline" id="H554705D4E6FD477F8F070DD65CECC61C" indent="up1"><enum>(60)</enum><subparagraph commented="no" display-inline="yes-display-inline" id="H88B34267600940A59D51EF5360A4326B"><enum>(A)</enum><text display-inline="yes-display-inline">The term <quote>xylazine</quote> means the substance xylazine as well as its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible.</text></subparagraph><subparagraph id="H744584DC11114BF2B64F867A803CC25D" indent="up1"><enum>(B)</enum><text>Except as provided in subparagraph (E), such term does not include a substance described in subparagraph (A) to the extent—</text><clause id="H813AF6757BE74084A5107A69DA7E92C5"><enum>(i)</enum><text display-inline="yes-display-inline">such substance is an animal drug that has been approved by the Secretary of Health and Human Services under section 512 of the Federal Food, Drug, and Cosmetic Act and such substance’s use or intended use conforms to the approved application, including the manufacturing, importation, holding, or distribution for such use; or</text></clause><clause id="H68F042C36AB649C9993ACBCE1BD6DD29"><enum>(ii)</enum><text display-inline="yes-display-inline">such substance is used or intended for use in animals other than humans as permitted under section 512(a)(4) of the Federal Food, Drug, and Cosmetic Act.</text></clause></subparagraph><subparagraph id="H479F148D3D0949BF891842DE83C414CE" indent="up1"><enum>(C)</enum><text display-inline="yes-display-inline">If any person prescribes, dispenses, distributes, manufactures, or imports xylazine for human use, such person shall be considered to have prescribed, dispensed, distributed, manufactured, or imported xylazine not subject to an exclusion under subparagraph (B).</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></subsection><subsection id="HB09A552425204279BF01597BA3805003" commented="no"><enum>(b)</enum><header>Placement of xylazine on schedule III</header><text>Schedule III in section 202(c) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/812">21 U.S.C. 812(c)</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" id="HB9D881CE556549D4999B93B0F710B013" display-inline="no-display-inline"><subsection id="HDF5BF1B79F8F4D3AAC4F8BFE74F28FF8" commented="no"><enum>(f)</enum><text display-inline="yes-display-inline">Xylazine.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H227C9F65D8A64E61893AE3E28CE4889C"><enum>(c)</enum><header>ARCOS tracking</header><text>Section 307(i) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/827">21 U.S.C. 827(i)</external-xref>) is amended—</text><paragraph id="HDF8DED06022F4BEAB6D12408C30D1E71"><enum>(1)</enum><text>in the matter preceding paragraph (1)—</text><subparagraph id="H0213AD95895449A49D368DA74EEA82CD"><enum>(A)</enum><text>by inserting <quote>or xylazine</quote> after <quote>gamma hydroxybutyric acid</quote>;</text></subparagraph><subparagraph id="HEA48492F4C6143BF8971975AECDD7BA1"><enum>(B)</enum><text>by inserting <quote>or 512</quote> after <quote>section 505</quote>; and</text></subparagraph><subparagraph id="H0231C6E1388D435DB97C9ED4CC46B2E1"><enum>(C)</enum><text>by inserting <quote>respectively,</quote> after <quote>the Federal Food, Drug, and Cosmetic Act,</quote>; and</text></subparagraph></paragraph><paragraph id="H4923A69F61F44CC19A21D2747CE62568"><enum>(2)</enum><text>in paragraph (6), by inserting <quote>or xylazine</quote> after <quote>gamma hydroxybutyric acid</quote>.</text></paragraph></subsection><subsection id="HC81812B51EA645258A6DC8A12363FAFE"><enum>(d)</enum><header>Report to Congress on xylazine</header><paragraph id="H7B29907D6EA04CBA845B2806F37D38C7"><enum>(1)</enum><header>Initial report</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this Act, the Attorney General, acting through the Administrator of the Drug Enforcement Administration and in coordination with the Commissioner of Food and Drugs, shall submit to Congress a report on the prevalence of illicit use of xylazine in the United States and the impacts of such use, including—</text><subparagraph id="HEEB488AF738A4B60BE9A7BF8ACBBA8AC"><enum>(A)</enum><text>where the drug is being diverted;</text></subparagraph><subparagraph id="HE258B1D1154F4F76BF14818E546F7271"><enum>(B)</enum><text>where the drug is originating;</text></subparagraph><subparagraph id="HC9F5722AB8234134818EAA635F06D125"><enum>(C)</enum><text>whether any analogues to such drug present a substantial risk of abuse;</text></subparagraph><subparagraph id="HB86BF535F1E04C8BAD6E65DCD628B4C6"><enum>(D)</enum><text>whether and to what extent the illicit supply of xylazine derives from the licit supply chain; and</text></subparagraph><subparagraph id="H40CC8B5429D54488A103104431FF24E7"><enum>(E)</enum><text display-inline="yes-display-inline">recommendations for Congress with respect to whether xylazine should be transferred to another schedule under section 202 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/812">21 U.S.C. 812</external-xref>).</text></subparagraph></paragraph><paragraph id="H36A9BC1C7D1D40879DE25AEA20B56F82"><enum>(2)</enum><header>Additional report</header><text display-inline="yes-display-inline">Not later than 3 years after the date of enactment of this Act, the Attorney General, acting through the Administrator of the Drug Enforcement Administration and in coordination with the Commissioner of Food and Drugs, shall submit to Congress a report updating Congress on the prevalence of xylazine trafficking, misuse, and proliferation in the United States, including—</text><subparagraph id="H1BE0FAF5713E414FBEC646924DF008D7"><enum>(A)</enum><text>the status and results of research on the impact xylazine has on human health; and</text></subparagraph><subparagraph id="H2F8D519FAFC94E84BE650D423BF61357"><enum>(B)</enum><text display-inline="yes-display-inline">the effects of the classification of xylazine under the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/801">21 U.S.C. 801 et seq.</external-xref>) on the prevalence of xylazine trafficking, misuse, and proliferation in the United States.</text></subparagraph></paragraph><paragraph id="H8C8DCC8B021C45BB9361E710B69FAD88"><enum>(3)</enum><header>Obtaining official data</header><text display-inline="yes-display-inline">The Attorney General, acting through the Administrator of the Drug Enforcement Administration and in coordination with the Commissioner of Food and Drugs, may secure directly from any department or agency of the United States documents, statistical data, and other information necessary to carry out paragraphs (1) and (2). Upon receipt of a request from the Attorney General for such documents, data, and information, the head of the department or agency shall, in accordance with applicable procedures for the appropriate handling of classified information, promptly provide reasonable access to such documents, data, and information.</text></paragraph><paragraph id="HA9BDB361805D4D21BD07C3BBDCABEDA7"><enum>(4)</enum><header>Views of experts from non-Federal entities</header><text display-inline="yes-display-inline">In developing the reports under paragraphs (1) and (2), the Attorney General, acting through the Administrator of the Drug Enforcement Administration and in coordination with the Commissioner of Food and Drugs, shall consult with, and take into consideration the views of, experts from appropriate non-Federal entities, including such experts from—</text><subparagraph id="HF5C09B51C5AE4B22881816F638842DAB"><enum>(A)</enum><text>the scientific and medical research community;</text></subparagraph><subparagraph id="H8DECC4A2A1A24FB7B79429AE921B47C9"><enum>(B)</enum><text>the State and local law enforcement community; and</text></subparagraph><subparagraph id="H1B413A8D1AE24FE7B2A06C90FB76D036"><enum>(C)</enum><text>community-based organizations.</text></subparagraph></paragraph></subsection></section><section id="H1AD0519841FA433E911FAE0C980D6CE3"><enum>204.</enum><header>Technical corrections</header><text display-inline="no-display-inline">Effective as if included in the enactment of <external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref>—</text><paragraph id="H8F006E12BAA2460CB0264C5DF11AA004"><enum>(1)</enum><text>section 1252(a) of division FF of <external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref> is amended, in the matter being inserted into section 302(e) of the Controlled Substances Act, by striking <quote>303(g)</quote> and inserting <quote>303(h)</quote>;</text></paragraph><paragraph id="HAD7A1A6808674CD7B6A8180E7E686D6C"><enum>(2)</enum><text>section 1262 of division FF of <external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref> is amended—</text><subparagraph id="H70FC5E2AB13D4CF7AEF50FA33C2457C2"><enum>(A)</enum><text>in subsection (a)—</text><clause id="H5518D05A634E4A11A56A3AF310C9C607"><enum>(i)</enum><text>in the matter preceding paragraph (1), by striking <quote>303(g)</quote> and inserting <quote>303(h)</quote>;</text></clause><clause id="HDE6FDC7F383E42F59E0FDA1E145E6E94"><enum>(ii)</enum><text>in the matter being stricken by subsection (a)(2), by striking <quote>(g)(1)</quote> and inserting <quote>(h)(1)</quote>; and</text></clause><clause id="H507D798566924C6FB3B28844331A5D71"><enum>(iii)</enum><text>in the matter being inserted by subsection (a)(2), by striking <quote>(g) Practitioners</quote> and inserting <quote>(h) Practitioners</quote>; and</text></clause></subparagraph><subparagraph id="H6D89E387D49C42E4B187BBD683901BA6"><enum>(B)</enum><text>in subsection (b)—</text><clause id="HB21772EB4B534377A249252BED080888"><enum>(i)</enum><text>in the matter being stricken by paragraph (1), by striking <quote>303(g)(1)</quote> and inserting <quote>303(h)(1)</quote>;</text></clause><clause id="H7BDB8B659859438EA4F2CA46804B8281"><enum>(ii)</enum><text>in the matter being inserted by paragraph (1), by striking <quote>303(g)</quote> and inserting <quote>303(h)</quote>;</text></clause><clause id="HAE28771A66924F978D6BCD11B79371E4"><enum>(iii)</enum><text>in the matter being stricken by paragraph (2)(A), by striking <quote>303(g)(2)</quote> and inserting <quote>303(h)(2)</quote>;</text></clause><clause id="H09B8B314CA8341C39CB3C5D5A845F012"><enum>(iv)</enum><text>in the matter being stricken by paragraph (3), by striking <quote>303(g)(2)(B)</quote> and inserting <quote>303(h)(2)(B)</quote>;</text></clause><clause id="H5E1BD3E346774BDE8D8DC78911C6300E"><enum>(v)</enum><text>in the matter being stricken by paragraph (5), by striking <quote>303(g)</quote> and inserting <quote>303(h)</quote>; and</text></clause><clause id="HAEAE6FE305D54DD69766EFA830DAD058"><enum>(vi)</enum><text>in the matter being stricken by paragraph (6), by striking <quote>303(g)</quote> and inserting <quote>303(h)</quote>; and</text></clause></subparagraph></paragraph><paragraph id="HE57EAA1D115A4CDEBCBF6FA2233A95BD"><enum>(3)</enum><text display-inline="yes-display-inline">section 1263(b) of division FF of <external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref> is amended—</text><subparagraph id="H1B8A4442E52E453783682B65B8A68BD0"><enum>(A)</enum><text>by striking <quote>303(g)(2)</quote> and inserting <quote>303(h)(2)</quote>; and</text></subparagraph><subparagraph id="H31554052EE194C50BB7292C540BF99E5"><enum>(B)</enum><text>by striking <quote>(<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823(g)(2)</external-xref>)</quote> and inserting <quote>(<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823(h)(2)</external-xref>)</quote>. </text></subparagraph></paragraph></section><section id="H7AAAD4909D224CFB9CF3CA70635ED4DE"><enum>205.</enum><header>Required training for prescribers of controlled substances</header><text display-inline="no-display-inline">Section 303 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823</external-xref>) is amended—</text><paragraph id="H79F655C0F89C4904A4167D594AA22233"><enum>(1)</enum><text display-inline="yes-display-inline">by redesignating the second subsection (l) (added by section 1263 of division FF of <external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref>) as subsection (m); and</text></paragraph><paragraph id="HF4BA84D3A53D44B2A49391758B18971E"><enum>(2)</enum><text>in subsection (m), as redesignated—</text><subparagraph id="H3AEA605F28D34051B10E24A02E45946A"><enum>(A)</enum><text>in paragraph (1)(A)(iv)—</text><clause id="H1F8F1A1CAD1D4EB48D74C54B9E77EEC1"><enum>(i)</enum><text>in subclause (I), by striking <quote>or the Commission for Continuing Education Provider Recognition (CCEPR)</quote> and inserting <quote>the Commission for Continuing Education Provider Recognition (CCEPR), the American Podiatric Medical Association, the Council on Podiatric Medical Education (CPME), or the Academy of General Dentistry</quote>;</text></clause><clause id="H0A667F2C97B54FDFA3C353689B01BFBD"><enum>(ii)</enum><text>by redesignating subclauses (II), (III), and (IV) as subclauses (III), (IV), and (V), respectively; and</text></clause><clause id="H822E1AFD93024CE293D1E6D7660472DF"><enum>(iii)</enum><text>by inserting after subclause (I) the following:</text><quoted-block style="OLC" id="HB383A513565D4503A9881852836E9E27" display-inline="no-display-inline"><subclause id="H641A54125E95484E9305BD20F8D8214A"><enum>(II)</enum><text display-inline="yes-display-inline">the American Academy of Family Physicians or any organization whose continuing medical education activity has been approved or accredited by the American Academy of Family Physicians;</text></subclause><after-quoted-block>; and</after-quoted-block></quoted-block></clause><clause id="H5384770A52644CB0B348171890F5850A"><enum>(iv)</enum><text>in subclause (V), as redesignated, by striking <quote>any organization approved by the Assistant Secretary for Mental Health and Substance Use, the ACCME, or the CCEPR</quote> and inserting <quote>any organization approved by the ACCME or the CCEPR</quote>;</text></clause></subparagraph><subparagraph id="H550CB26F6CC34499947AF1D06A8394CB"><enum>(B)</enum><text>in paragraph (1)(A)(v)—</text><clause id="HDD1FC5BBD3A9401FB5BAFA362B60B3A1"><enum>(i)</enum><text>by inserting <quote>podiatric medicine,</quote> after <quote>allopathic medicine, osteopathic medicine,</quote>; and</text></clause><clause id="HC88E1A25FFA24095A6C2AF7A5FDC9528"><enum>(ii)</enum><text>by striking <quote>allopathic or osteopathic medicine curriculum</quote> and inserting <quote>allopathic, osteopathic, or podiatric medicine curriculum</quote>;</text></clause></subparagraph><subparagraph id="H29E0BD2E8D7A496089BD12BEBB8B0DA8"><enum>(C)</enum><text>in paragraph (1)(B)(i), by striking <quote>or any other organization approved or accredited by the Assistant Secretary for Mental Health and Substance Use or the Accreditation Council for Continuing Medical Education</quote> and inserting <quote>the American Podiatric Medical Association, the Council on Podiatric Medical Education (CPME), the American Pharmacists Association, the Accreditation Council for Pharmacy Education, the American Optometric Association, the Academy of General Dentistry, the American Psychiatric Nurses Association, the American Academy of Nursing, the American Academy of Family Physicians, or any other organization approved or accredited by the American Academy of Family Physicians or the Accreditation Council for Continuing Medical Education</quote>; and</text></subparagraph><subparagraph id="H3AEE103F397445B6A00A284F0DF97E03"><enum>(D)</enum><text>in paragraph (1)(B)(ii), by striking <quote>from an accredited physician assistant school or accredited school of advanced practice nursing</quote> and inserting <quote>from an accredited physician assistant school, an accredited school of advanced practice nursing, or an accredited school of pharmacy</quote>.</text></subparagraph></paragraph></section></title><title id="H4DF0EB27199647F9BD4D71E1D672C354"><enum>III</enum><header>Medicaid</header><section id="H005E8ED40E684D088FF92B2BAD78D66E" display-inline="no-display-inline" section-type="subsequent-section"><enum>301.</enum><header>Extending requirement for State Medicaid plans to provide coverage for medication-assisted treatment</header><subsection id="HA50C4F4982FD4791AD9D657D3F739FF6"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1905 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396d">42 U.S.C. 1396d</external-xref>) is amended—</text><paragraph id="HBF5FE1141E4A4C0A9C8EA93434CB8284"><enum>(1)</enum><text>in subsection (a)(29), by striking <quote>for the period beginning October 1, 2020, and ending September 30, 2025,</quote> and inserting <quote>beginning on October 1, 2020,</quote>; and</text></paragraph><paragraph id="HA064F04A0FB2455196BB162303C3621F"><enum>(2)</enum><text>in subsection (ee)(2), by striking <quote>for the period specified in such paragraph, if before the beginning of such period the State certifies to the satisfaction of the Secretary</quote> and inserting <quote>if such State certifies, not less than every 5 years and to the satisfaction of the Secretary,</quote>.</text></paragraph></subsection><subsection id="H126D68555B514094B3DF6980C5CCD4D1"><enum>(b)</enum><header>Conforming amendment</header><text display-inline="yes-display-inline">Section 1006(b)(4)(A) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396a">42 U.S.C. 1396a</external-xref> note) is amended by striking <quote>, and before October 1, 2025</quote>.</text></subsection></section><section id="H9495CBC6C35F46D0AE1E4AD5CF0181F5" section-type="subsequent-section"><enum>302.</enum><header>Expanding required reports on T-MSIS substance use disorder data to include mental health condition data</header><subsection id="H174BCB9C051D41DD94DC004A51D443CF"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1015(a) of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1320d-2">42 U.S.C. 1320d–2</external-xref> note) is amended—</text><paragraph id="H4389C7ED07E541AEA5E376C7198436C6"><enum>(1)</enum><text>in the heading, by striking <quote><header-in-text level="subsection" style="OLC">substance use disorder data book</header-in-text></quote> and inserting <quote><header-in-text level="subsection" style="OLC">behavioral health data book</header-in-text></quote>; </text></paragraph><paragraph id="H4413A67740844BDFB246F7A3F69AE2BF"><enum>(2)</enum><text>in paragraph (2)—</text><subparagraph id="H91F63C7162F945C7B2071FC4B14E9735"><enum>(A)</enum><text>in the matter preceding subparagraph (A), by inserting <quote>, including as updated in accordance with paragraph (3),</quote> after <quote>paragraph (1)</quote>;</text></subparagraph><subparagraph id="HF15236C3F67844F6A714AE5CEC663C5B"><enum>(B)</enum><text>in subparagraph (A), by inserting <quote>, mental health condition, or a mental health condition co-occurring with substance use disorder</quote> after <quote>substance use disorder</quote>;</text></subparagraph><subparagraph id="HE733C9C9F2894E89BFBD87E1411E1757"><enum>(C)</enum><text>in subparagraph (B), by inserting <quote>and mental health treatment services</quote> after <quote>substance use disorder treatment services</quote>;</text></subparagraph><subparagraph id="H2F8B1900A17146CF8EAC402630F5E428"><enum>(D)</enum><text>in subparagraph (C)—</text><clause id="H73D36AFA6925462991F5B565C68B6D62"><enum>(i)</enum><text>by inserting <quote>, mental health condition, or a mental health condition co-occurring with a substance use disorder diagnosis</quote> after <quote>substance use disorder diagnosis</quote>; and</text></clause><clause id="H880B8799871F4C63BA37C9D281F4874F"><enum>(ii)</enum><text>by inserting <quote>or mental health treatment services, respectively,</quote> after <quote>substance use disorder treatment services</quote>;</text></clause></subparagraph><subparagraph id="H761C939BF72B445C92580FD0ED1714A0"><enum>(E)</enum><text>in subparagraph (D), by inserting <quote>, mental health condition, or a mental health condition co-occurring with substance use disorder</quote> after <quote>substance use disorder diagnosis</quote>;</text></subparagraph><subparagraph id="H3886BAB91BD34610B79E45E4C08FB722"><enum>(F)</enum><text>in subparagraph (E), by inserting <quote>or mental health treatment</quote> after <quote>substance use disorder treatment</quote>; and</text></subparagraph><subparagraph id="H467578385D444065A1157F44E0A7610F"><enum>(G)</enum><text>in subparagraph (F), by inserting <quote>, individuals with a mental health condition who receive mental health treatment services, and individuals with a co-occurring mental health condition and substance use disorder who receive substance use disorder treatment services and mental health treatment services,</quote> after <quote>substance use disorder treatment services</quote>; and</text></subparagraph></paragraph><paragraph id="H2B83C33F244C42BB9D280B10CB2BAFA6"><enum>(3)</enum><text>in paragraph (3), by striking <quote>through 2024</quote>.</text></paragraph></subsection><subsection id="HFC7A0E157C114687B281E6B91C389EAD" commented="no"><enum>(b)</enum><header>Application</header><text display-inline="yes-display-inline">The amendments made by subsection (a)(1) shall apply beginning with respect to the first update made pursuant to section 1015(a)(3) of the SUPPORT for Patients and Communities Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1320d-2">42 U.S.C. 1320d–2</external-xref> note) after the date that is 12 months after the date of enactment of this Act.</text></subsection></section><section id="H242B652BD477443EB30006B12B73A02A"><enum>303.</enum><header>Monitoring prescribing of antipsychotic medications</header><text display-inline="no-display-inline">Section 1902(oo)(1)(B) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396a">42 U.S.C. 1396a(oo)(1)(B)</external-xref>) is amended—</text><paragraph id="H87B2EDEA8A354A6BB124816C3630DBC0" display-inline="no-display-inline"><enum>(1)</enum><text>in the subparagraph heading, by striking <quote><header-in-text level="subparagraph" style="OLC">by children</header-in-text></quote>; </text></paragraph><paragraph id="H9C4740FB524D40E9A6694602BF0DB503" commented="no"><enum>(2)</enum><text>by inserting <quote>, and beginning on the date that is 24 months after the date of enactment of Support for Patients and Communities Reauthorization Act, individuals over the age of 18, individuals receiving home and community-based services (as defined in section 9817(a)(2)(B) of <external-xref legal-doc="public-law" parsable-cite="pl/117/2">Public Law 117–2</external-xref>), and individuals residing in institutional care settings (including nursing facilities, intermediate care facilities for individuals with intellectual disabilities, and other such institutional care settings) enrolled,</quote> after <quote>children enrolled</quote>; and</text></paragraph><paragraph id="HD6C3C559521F454D8FBDC078494708D2"><enum>(3)</enum><text>by striking <quote>not more than the age of 18 years</quote> and inserting <quote>subject to the program</quote>.</text></paragraph></section><section id="H30662AECD0C344BD98FA820E62B367B9" section-type="subsequent-section" display-inline="no-display-inline"><enum>304.</enum><header>Lifting the IMD exclusion for substance use disorder</header><subsection id="H11C08D6932C5483D96B9F48AF7E395C6"><enum>(a)</enum><header>Making permanent State Plan Amendment Option To Provide Medical Assistance for Certain Individuals Who Are Patients in Certain Institutions for Mental Diseases</header><text display-inline="yes-display-inline">Section 1915(l)(1) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396n">42 U.S.C. 1396n(l)(1)</external-xref>) is amended by striking <quote>With respect to calendar quarters beginning during the period beginning October 1, 2019, and ending September 30, 2023,</quote> and inserting <quote>With respect to calendar quarters beginning on or after October 1, 2019,</quote>.</text></subsection><subsection id="H5A78C74FDC7642638784DE5FA5729643"><enum>(b)</enum><header>Maintenance of effort revision</header><text>Section 1915(l)(3) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396n">42 U.S.C. 1396n(l)(3)</external-xref>) is amended—</text><paragraph id="H4D8C160FB8474E05927B906D4642A1FB"><enum>(1)</enum><text>in subparagraph (A)-—</text><subparagraph id="H11D9152A4556434BBB68D9FEB3F78B59"><enum>(A)</enum><text>in the matter preceding clause (i), by striking <quote>other than under this title</quote>; and </text></subparagraph><subparagraph id="H73B00CEBCE8C4EF583FC6BB9EBDE7398"><enum>(B)</enum><text>in clause (i), by striking <quote>or, if higher,</quote> and all that follows through <quote>in accordance with this subsection</quote>; and</text></subparagraph></paragraph><paragraph id="H93877AD5305F4658A9EEB86A9AD8D6DF"><enum>(2)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="H114A63CEFBF347D1B1D88C1338F9BDDB" display-inline="no-display-inline"><subparagraph id="HBA149EE547E744E682EB59DE3DAE09E7"><enum>(D)</enum><header>Application of maintenance of effort requirements to certain States</header><text display-inline="yes-display-inline">In the case of a State with a State plan amendment in effect on the date of the enactment of this subparagraph, for the 1-year period beginning on such date, the provisions of subparagraph (A) shall be applied as if the amendments to such subparagraph made by the Support for Patients and Communities Reauthorization Act had never been made.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="HE210288690C94F448C58909B522375FD"><enum>(c)</enum><header>Additional requirements</header><paragraph id="H050882839E684CE3B6EECB13F4A578EC"><enum>(1)</enum><header>In general</header><subparagraph id="HEC4A4AC759394AB6BA46D706E1C93BF6"><enum>(A)</enum><header>General requirements</header><text>Section 1915(l)(4) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396n">42 U.S.C. 1396n(l)(4)</external-xref>) is amended—</text><clause id="HB50497D73C524696A74830FDDA7905FB"><enum>(i)</enum><text>in subparagraph (A), by striking <quote>through (D)</quote> and inserting <quote>through (F)</quote>;</text></clause><clause id="H8DFD4501736C49B8B481479330757390"><enum>(ii)</enum><text>in subparagraph (D), in the matter preceding clause (i), by inserting <quote>have in place evidence-based, substance use disorder-specific individual placement criteria and utilization management approach to ensure placement of such individual in an appropriate level of care and shall</quote> after <quote>State shall</quote>; and</text></clause><clause id="H08FA5236BC4D41CCBA8E3B8D7562977C"><enum>(iii)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="H4F211BE8948143B8992ACCD66ED5F78F" display-inline="no-display-inline"><subparagraph id="HC5459FF3490E4087B89EB21A7720B341"><enum>(E)</enum><header>Review process</header><text display-inline="yes-display-inline">The State shall have in place a process to review the compliance of eligible institutions for mental diseases with evidence-based, substance use disorder-specific program standards for eligible individuals specified by the State.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></clause></subparagraph><subparagraph id="H70C4C3ECCE624D25BD89B5B14ECB449C"><enum>(B)</enum><header>Effective date</header><text>The amendments made by subparagraph (A) shall apply with respect to medical assistance furnished in calendar quarters beginning on or after October 1, 2025.</text></subparagraph></paragraph><paragraph id="H320DD7654B79490B9E94550DA6746581"><enum>(2)</enum><header>One-time assessment</header><text display-inline="yes-display-inline">Section 1915(l)(4) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396n">42 U.S.C. 1396n(l)(4)</external-xref>), as amended by paragraph (1), is further amended by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="H53CD3F9CEBA34947A7133CB94AD2C0BA" display-inline="no-display-inline"><subparagraph id="H0F15EAD750664D3282FBCAB559237600"><enum>(F)</enum><header>Assessment</header><clause id="H85A9C70693BF41C78EAFB47F7DBA49EA"><enum>(i)</enum><header>In general</header><text>The State shall, not later than 12 months after the approval of a State plan amendment described in this subsection (or, in the case such State has such an amendment approved as of the date of the enactment of this subparagraph, not later than 12 months after such date), commence an assessment of—</text><subclause id="H8540E543C6B64289856F757864610C55"><enum>(I)</enum><text>the availability of treatment for individuals enrolled under a State plan under this title (or waiver of such plan) in each level of care described in subparagraph (C); and</text></subclause><subclause id="H16A4E7ABDC964D18986FE2123A0DF256"><enum>(II)</enum><text>the availability of medication-assisted treatment and medically supervised withdrawal management services for such individuals.</text></subclause></clause><clause id="H2172AB6089604A3DA2F4FC02A20B5B43"><enum>(ii)</enum><header>Required completion</header><text>The State compete an assessment described in clause (i) not later than 12 months after the date the State commences such assessment.</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph><paragraph id="H7734119066564F43B6F1138F245AA152"><enum>(3)</enum><header>Clarification of levels of care</header><text display-inline="yes-display-inline">Section 1915(l)(7)(A) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396n">42 U.S.C. 1396n(l)(7)(A)</external-xref>) is amended by inserting <quote>(or any successor publication)</quote> before the period.</text></paragraph></subsection></section><section id="HE83C43754E094EDD8B4A46545538CBD4" display-inline="no-display-inline" section-type="subsequent-section"><enum>305.</enum><header>Prohibition on termination of enrollment due to incarceration</header><subsection id="H67BDFB4776514ACD942E78D43F637EB0"><enum>(a)</enum><header>Medicaid</header><paragraph id="HF3E85D1E0F534ACE89EDAAF0E2B6ABA7"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1902(a)(84)(A) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396a">42 U.S.C. 1396a(a)(86)(A)</external-xref>), as amended by section 5122(a)(2) of the Consolidated Appropriations Act, 2023 (<external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref>), is further amended—</text><subparagraph id="H9310669FDD494078BBFC952CDFB38957"><enum>(A)</enum><text>by striking <quote>under the State plan</quote> and inserting <quote>under the State plan (or waiver of such plan)</quote>;</text></subparagraph><subparagraph id="H4AAF06D5326F42848A17128580CCCC21"><enum>(B)</enum><text>by striking <quote>who is an eligible juvenile (as defined in subsection (nn)(2))</quote>;</text></subparagraph><subparagraph id="HEAD4E02C3AD1494B872FB88ADE4CB561"><enum>(C)</enum><text>by striking <quote>because the juvenile</quote> and inserting <quote>because the individual</quote>;</text></subparagraph><subparagraph id="H8574C1EB7B0A429793370FCF012D557F"><enum>(D)</enum><text>by striking <quote>during the period the juvenile</quote> and inserting <quote>during the period the individual</quote>; and</text></subparagraph><subparagraph id="HF5D0323CE020492FA6B6021B12617B8C"><enum>(E)</enum><text>by inserting <quote>such an individual who is an eligible juvenile (as defined in subsection (nn)(2)) or a woman during pregnancy (and during the 60-day beginning on the last day of pregnancy) and</quote> after <quote>or in the case of</quote>.</text></subparagraph></paragraph><paragraph id="H40C240054A024E2A9962D520CFDF901A"><enum>(2)</enum><header>Effective date</header><text>The amendments made by—</text><subparagraph id="HF246C60CFCD94058BF9AB51D91E598EC"><enum>(A)</enum><text>subparagraph (A) of paragraph (1) shall take effect on the date of the enactment of this Act; and</text></subparagraph><subparagraph id="H385B2E0797484892ABC8800F2C2EB008"><enum>(B)</enum><text>subparagraphs (B) through (E) of paragraph (1) shall take effect on January 1, 2025.</text></subparagraph></paragraph></subsection><subsection id="H32E2D9409F4C49C58684A42D0A178A17"><enum>(b)</enum><header>CHIP</header><paragraph id="H2ACCBC869FFF494F904D7C0E2E10BFF6"><enum>(1)</enum><header>In general</header><text>Section 2102(d)(1)(A) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1397bb">42 U.S.C. 1397bb(d)(1)(A)</external-xref>) is amended—</text><subparagraph id="H405FF396E0AD4298AFF38D1ED263D32E"><enum>(A)</enum><text>by inserting <quote>or pregnancy-related</quote> after <quote>child health</quote>;</text></subparagraph><subparagraph id="H6EF941FBB05C40AD9C875EFE2D4B2D36"><enum>(B)</enum><text>by inserting <quote>or targeted low-income pregnant woman</quote> after <quote>targeted low-income child</quote>;</text></subparagraph><subparagraph id="H44BB9A477FF446E69D9EE0AAFBBD6861"><enum>(C)</enum><text>by inserting <quote>or pregnant woman</quote> after <quote>because the child</quote>; and</text></subparagraph><subparagraph id="H0EFE2B03FE924DA6A54164B22A2C7AF9"><enum>(D)</enum><text>by inserting <quote>or pregnant woman</quote> after <quote>during the period the child</quote>.</text></subparagraph></paragraph><paragraph id="H6702200BE9824CEEB5C70475DC023126"><enum>(2)</enum><header>Effective date</header><text>The amendments made by paragraph (1) shall apply beginning January 1, 2025.</text></paragraph></subsection><subsection id="H16DBD612E2DB4340A300E1743112532F"><enum>(c)</enum><header>Technical correction</header><text>Section 1902(nn)(2)(A) of the Social Security Act (42 U.S.C. 1395a(a)(nn)(2)(A)) is amended by striking <quote>State plan</quote> and inserting <quote>State plan (or waiver of such plan)</quote>. </text></subsection></section><section id="HD129DAEE886F4FE0AD8468A1CE7D33E5"><enum>306.</enum><header>State option relating to inmates who are pregnant women pending disposition of charges</header><subsection id="H54E2A75E439044A894CBDCA536BC105F"><enum>(a)</enum><header>State option</header><paragraph id="H159A865957E04548BAA5E7D7FC23A1C9"><enum>(1)</enum><header>Medicaid</header><text display-inline="yes-display-inline">The subdivision (A) of section 1905(a) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396d">42 U.S.C. 1396d(a)</external-xref>) following paragraph (31) of such section, as amended by section 5122 of the Consolidated Appropriations Act, 2023 (<external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref>), is further amended by inserting <quote>or a woman during pregnancy (and during the 60-day beginning on the last day of pregnancy)</quote> after <quote>(as defined in section 1902(nn)(2))</quote>.</text></paragraph><paragraph id="H298DA607D391467CAB969DE2F755885D"><enum>(2)</enum><header>CHIP</header><text display-inline="yes-display-inline">Section 2110(b)(7) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1397jj">42 U.S.C. 1397jj(b)(10)</external-xref>), as amended by section 5122 of the Consolidated Appropriations Act, 2023 (<external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref>), is further amended—</text><subparagraph id="H40F3F9384C064DA8BB9056C84939B9F6"><enum>(A)</enum><text>by inserting <quote>a woman during pregnancy (and during the 60-day beginning on the last day of pregnancy) or</quote> after <quote>At the option of the State,</quote>; and</text></subparagraph><subparagraph id="H1F95D9E519FA4F5587C6A204FDDE66FA"><enum>(B)</enum><text>by striking <quote>during the period that the child</quote> and inserting <quote>during the period that the woman or child</quote>. </text></subparagraph></paragraph><paragraph id="HB3486BD639C54B8CB1A008861F220025"><enum>(3)</enum><header>Effective date</header><text>The amendments made by this subsection shall take effect on January 1, 2025. </text></paragraph></subsection><subsection id="HC2219BD44E6C4DE58EDFE0BE9196719E" display-inline="no-display-inline"><enum>(b)</enum><header>Technical correction</header><text>Section 5122(a)(1) of the Consolidated Appropriations Act, 2023 (<external-xref legal-doc="public-law" parsable-cite="pl/117/328">Public Law 117–328</external-xref>) is amended by striking <quote>after</quote> and all that follows through the period at the end and inserting <quote>after <quote>or in the case of an eligible juvenile described in section 1902(a)(84)(D) with respect to the screenings, diagnostic services, referrals, and targeted case management services required under such section</quote>.</quote>. </text></subsection></section><section id="HDC107FEBDE4C4E2AA656E6E2BA052FF4" section-type="subsequent-section" display-inline="no-display-inline"><enum>307.</enum><header>Permitting access to medical assistance under the Medicaid program for foster youth</header><subsection id="H2A103C7F8209461E8206F9AC5B2C1A44" display-inline="no-display-inline"><enum>(a)</enum><header>In general</header><text>Section 1905(a) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396d">42 U.S.C. 1396d(a)</external-xref>) is amended by adding at the end the following new sentence: <quote>In the case of an individual who is under the age of 21 and who is a patient in an institution for mental diseases that is a qualified residential treatment program (as defined in section 472(k)(4)), the exclusion from the definition of medical assistance set forth in the subdivision (B) following the last numbered paragraph of this subsection shall not apply with respect to items and services furnished to such an individual when received outside of such program.</quote>.</text></subsection><subsection id="HCF9466E7BB6F4225812487C959C81D0A"><enum>(b)</enum><header>Effective date</header><text>The amendment made by paragraph (1) shall apply with respect to medical assistance furnished in calendar quarters beginning on or after January 1, 2025.</text></subsection></section></title><title id="HFE0DDC1805094EDFB7A821787DCFF7B6"><enum>IV</enum><header>Offsets</header><section id="H09269317D65F459A94CE372040E77C46"><enum>401.</enum><header>Promoting value in Medicaid managed care</header><text display-inline="no-display-inline">Section 1903(m)(9)(A) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396b">42 U.S.C. 1396b(m)(9)(A)</external-xref>) is amended by striking <quote>(and before fiscal year 2024)</quote>.</text></section></title></legis-body><attestation><attestation-group><attestation-date date="20231212" chamber="House">Passed the House of Representatives December 12, 2023.</attestation-date><attestor display="yes">Kevin F. McCumber,</attestor><role>Clerk.</role></attestation-group></attestation></bill> 

